NEW YORK, Oct 2 (Reuters) – Arbor Pharmaceuticals LLC is exploring a sale that could fetch more than $1 billion for the privately-held specialty drugmaker, according to people familiar with the…
Source: Reuters: Private Equity
NEW YORK, Oct 2 (Reuters) – Arbor Pharmaceuticals LLC is exploring a sale that could fetch more than $1 billion for the privately-held specialty drugmaker, according to people familiar with the…
Source: Reuters: Private Equity
